CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PHIBRO ANIMAL HEALTH CORP

PAHC
$2.40BMid Cap

Next catalyst

No upcoming catalyst in our data

No upcoming FDA decision, filing or trial readout is on file for PAHC. That does not mean none is planned.

Get an email about PAHC's next catalysts

Track PHIBRO ANIMAL HEALTH (PAHC) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Catalyst Timeline

0 upcoming, 1 past

No catalysts found.

Market Overview

Stock performance and key metrics

NASDAQPharmaceutical PreparationsπŸ‡ΊπŸ‡ΈNorth AmericaTEANECK1.4K employees

Phibro Animal Health Corporation is an American animal health and mineral nutrition company. Its products include antibacterials, anticoccidials, anthelmintics, as well as animal nutrition and vaccines for livestock. The company operates through three segments Mineral Nutrition, Performance Materials, and Animal Health, from which most of its revenue is derived. The company operates in the United States, Latin America, Canada, Europe, Middle East, Africa, and Asia-Pacific. It is incorporated in Delaware.

Website
Drug Pipeline

No drugs found in this phase.

Frequently asked questions

When is PHIBRO ANIMAL HEALTH CORP's next FDA catalyst?β†’

CatalystAlert tracks every upcoming catalyst for PHIBRO ANIMAL HEALTH CORP (PAHC) β€” PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β€” each confidence-rated as confirmed, estimated or AI-detected.

How do I track PAHC biotech catalysts?β†’

Add PAHC to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PHIBRO ANIMAL HEALTH CORP's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply